Skip to the page

Data / Form D filings / EpiBone, Inc.

EpiBone, Inc.: Form D filings

EpiBone, Inc., a company in New York, NY, filed 4 Form D notices with the SEC between 2020 and 2025. The latest, on October 24, 2025, reports $4.3 million sold of a $4.3 million offering to 131 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
521 5TH AVE, 17TH FLOOR, New York, NY, 10175
Phone
(212) 653-8828
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1798436

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 24, 2025New notice$4,300,506$4,287,429$13,077131Sep 2, 2025sec.gov
Dec 27, 2022New notice$36,762,017$18,453,016$18,309,00151Dec 12, 2022sec.gov
Feb 12, 2021New notice$5,000,000$750,000$4,250,0004Feb 3, 2021sec.gov
Feb 6, 2020New notice$26,599,917$24,328,308$2,271,609140Jan 23, 2020sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Robert LangerDirector
Gordana Vunjak-NovakovicDirector
Nina TandonExecutive Officer, Director
Sarindr BhumiratanaExecutive Officer, Director
David ZhuDirector

Other companies in New York that filed recently

Every Form D from the week of Oct 20, 2025 · All recent filings in New York · All recent Other filings

Read from SEC EDGAR. Amount sold is what EpiBone, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.